Página 3 - Melhores Câncer de testículo médicos - TOP-102 médicos

O Dr. Dror Levin é especialista em oncologia pediátrica, com foco em câncer ósseo (sarcoma) em crianças no Sourasky Medical Center.

• Diretor do departamento de hematologia e oncologia pediátrica do Sourasky Medical Center
• Especializado em hematologia e oncologia pediátrica no Schneider Children's Medical Center
• Membro da Sociedade de Hematologia e Oncologia Pediátrica de Israel (ISPHO)
• Capacitado em oncologia de ossos e tecidos moles no Rizzoli Orthopaedic Institute, na Itália

A Dra. Turkan Ozturk Topcu é especialista em uma ampla gama de cânceres, incluindo o câncer testicular, com formação em centros internacionais de ponta como o MD Anderson e o Sunnybrook Odette.

• Especialista em Oncologia Médica desde 2015 pela Karadeniz Technical University
• Formação no MD Anderson Cancer Center nos EUA
• Especialização adicional no Sunnybrook Odette Cancer Center no Canadá
• Trabalhar com protocolos de tratamento avançados para o cancro testicular

O Prof. Haim Matskin é uma autoridade líder em oncourologia, especializado no tratamento do cancro testicular no Sourasky Medical Center.

• Chefiar o Departamento de Urologia no Sourasky Medical Center
• Ser especialista em braquiterapia e crioterapia para tumores malignos
• Ser membro da Associação Médica de Israel e de associações internacionais de urologia

O Prof. Jack Baniel lidera a urologia no Rabin Medical Center, especializando-se em cirurgias de câncer com preservação de nervos e precisão robótica. Fundou o departamento de oncourologia no Hospital Beilinson.

• Realizar reconstrução da bexiga e prostatectomia robótica
• Publicar mais de 100 artigos científicos sobre uro-oncologia
• Ser membro das associações europeia e americana de urologia
• Participar em colaborações globais de investigação clínica

O Dr. Avi Beri é especialista em tratamentos urológicos abrangentes no Sourasky Medical Center, incluindo prostatectomia e RTUP.

• Especialista em tratamento de cálculos renais e vasectomia
• Oferecer consultas de urologia para diversas condições
• Concentrar-se em ajudar os pacientes a alcançar uma vida saudável

O Professor Associado Tahsin Ozatli é especialista em cancros da mama, do pulmão e gastrointestinais no Hospital Universitário Istinye Liv.

• Especialista em Medicina Interna com experiência em várias clínicas oncológicas na Turquia
• Promovido a Professor Associado em 2016
• Estudos na Faculdade de Medicina da Universidade de Selcuk

O Professor Associado Dr. Yusuf Acikgoz traz a experiência internacional em oncologia da Ohio State University para o Hospital Universitário Lokman Hekim de Ancara.

• Especializar-se em oncologia médica com foco em cancro testicular
• Participar em ensaios clínicos de Fase III, como CheckMate-649 e Fortitude-101
• Ser certificado em Boas Práticas Clínicas e Proteção de Indivíduos Humanos
• Ser membro da American Society of Clinical Oncology (ASCO)

O Professor Cemil Bilir traz mais de 15 anos de experiência especializada em oncologia médica, com formação em instituições de topo como a Cleveland Clinic e a Northeastern University.

• Especializar-se no tratamento do cancro testicular utilizando os protocolos mais recentes
• Ser membro da ASCO e da ESMO – manter-se atualizado com os padrões globais
• Ensinar futuros oncologistas como professor na Universidade de Sakarya
• Concluir uma bolsa de especialização no Centro de Biotecnologia Farmacêutica da Northeastern University

O Professor Associado Nail Paksoy é especializado no tratamento do cancro testicular, com uma bolsa de oncologia médica da Universidade de Istambul e certificação da ESMO.

• Participar em 8 ensaios clínicos internacionais para tratamentos oncológicos
• Publicar múltiplos estudos sobre cancros metastáticos em revistas especializadas
• Ser membro da Sociedade Europeia de Oncologia Médica (ESMO)

Mais de 30 anos de especialização em viroterapia – A Dra. Jaunalksne lidera o Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins.

• Graduada pelo Instituto Médico de Riga com estágio em Medicina Interna
• Chefe do Centro de Imunologia Clínica – supervisionar tratamentos imunológicos de ponta
• Focar em abordagens inovadoras de viroterapia para o tratamento do cancro

Especializado em oncologia médica, o Dr. Alemdar traz expertise focada em cancro testicular no Complexo Hospitalar Medical Park Antalya.

• Formado na Universidade de Akdeniz, uma das principais faculdades de medicina da Turquia
• Mais de 7 anos de experiência dedicada em oncologia médica
• Lidar tanto com o diagnóstico quanto com o planeamento do tratamento para o cancro testicular
• Trabalhar num hospital acreditado pela JCI com instalações oncológicas avançadas

O Dr. Ozden traz mais de 20 anos de experiência em medicina interna e oncologia médica, especializando-se em cancro testicular no Hospital VM Medical Park Pendik.

• Concluir a subespecialidade de oncologia médica na Faculdade de Medicina da Universidade de Kocaeli
• Praticar no Hospital Privado Safa de Bağcılar e no Hospital Batı Bahat de Küçükçekmece
• Licenciar-se na Faculdade de Medicina Cerrahpaşa da Universidade de Istambul

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Chefe do Departamento de Urologia do Rambam Medical Center, o Dr. Amiel é especializado em oncologia urológica.

• Vasta experiência no tratamento de câncer testicular
• Liderar um dos principais departamentos de urologia de Israel
• Focar em procedimentos cirúrgicos oncológicos

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.